James Lankford actually said...

"I am concerned that the FDA has a requirement and that they are trying to fulfill that requirement to be able to get the drug to market, but that it may inadvertently doom some child or some adult to ..."

"How do you all deal with the moral issues and the ethical issues of leaving those that are getting the placebo--knowing that they are in a terminal status, as opposed to trying to shift them over?"

"I would be glad to be able to get that, because that may broaden out and accelerate some of the process as well."

"So what I want to be able to evaluate is, before the money goes out the door, we have a set of evaluation metrics that we know about this grant."